who medicines strategy - libdoc.who.int - World Health Organization
who medicines strategy - libdoc.who.int - World Health Organization who medicines strategy - libdoc.who.int - World Health Organization
WHO MEDICINES STRATEGY 2004-2007 | 26COMPONENT 1NATIONAL POLICIES ON MEDICINES
COMPONENTS OF THE STRATEGY | 27A NATIONAL MEDICINESPOLICY:National medicines policies (NMPs) arecommitments to goals and guides for action. Theyprovide frameworks within which priorities areset, the activities of the pharmaceutical sectorcan be coordinated, and legislation developedto support public health needs. They cover boththe public and the private sectors and involveall the main actors in the pharmaceutical field.While recognizing that each country’s situationis unique, WHO proposes 4 that the generalobjectives of medicines policies should be toensure:> Access: equitable availability and affordabilityof essential medicines> Quality: quality, safety, and efficacy of allmedicines> Rational use: therapeutically sound andcost-effective use of medicines by healthprofessionals and consumers.> presents a formal record ofvalues, aspirations, aims,decisions, and mediumtolong-term governmentcommitments> defines the national goalsand objectives for thepharmaceutical sector, and setspriorities> identifies the strategies neededto meet those objectives, andthe various actors responsiblefor implementing the maincomponents of the policy> creates a forum for nationaldiscussions on these issues.
- Page 10 and 11: WHO MEDICINES STRATEGY 2004-2007 |x
- Page 12 and 13: WHO MEDICINES STRATEGY 2004-2007 |x
- Page 14 and 15: WHO MEDICINES STRATEGY 2004-2007 |
- Page 23: MEDICINESAND PUBLIC HEALTH
- Page 26 and 27: WHO MEDICINES STRATEGY 2004-2007 |
- Page 28 and 29: WHO MEDICINES STRATEGY 2004-2007 |
- Page 30 and 31: WHO MEDICINES STRATEGY 2004-2007 |
- Page 32 and 33: WHO MEDICINES STRATEGY 2004-2007 |
- Page 34 and 35: WHO MEDICINES STRATEGY 2004-2007 |
- Page 36 and 37: WHO MEDICINES STRATEGY 2004-2007 |
- Page 40 and 41: WHO MEDICINES STRATEGY 2004-2007 |
- Page 42 and 43: WHO MEDICINES STRATEGY 2004-2007 |
- Page 44 and 45: WHO MEDICINES STRATEGY 2004-2007 |
- Page 46 and 47: WHO MEDICINES STRATEGY 2004-2007 |
- Page 48 and 49: WHO MEDICINES STRATEGY 2004-2007 |
- Page 50 and 51: WHO MEDICINES STRATEGY 2004-2007 |
- Page 52 and 53: WHO MEDICINES STRATEGY 2004-2007 |
- Page 54 and 55: WHO MEDICINES STRATEGY 2004-2007 |
- Page 56 and 57: WHO MEDICINES STRATEGY 2004-2007 |
- Page 58 and 59: WHO MEDICINES STRATEGY 2004-2007 |
- Page 60 and 61: WHO MEDICINES STRATEGY 2004-2007 |
- Page 62 and 63: WHO MEDICINES STRATEGY 2004-2007 |
- Page 64 and 65: WHO MEDICINES STRATEGY 2004-2007 |
- Page 66 and 67: WHO MEDICINES STRATEGY 2004-2007 |
- Page 68 and 69: WHO MEDICINES STRATEGY 2004-2007 |
- Page 70 and 71: WHO MEDICINES STRATEGY 2004-2007 |
- Page 72 and 73: WHO MEDICINES STRATEGY 2004-2007 |
- Page 74 and 75: WHO MEDICINES STRATEGY 2004-2007 |
- Page 76 and 77: WHO MEDICINES STRATEGY 2004-2007 |
- Page 78 and 79: WHO MEDICINES STRATEGY 2004-2007 |
- Page 80 and 81: WHO MEDICINES STRATEGY 2004-2007 |
- Page 82 and 83: WHO MEDICINES STRATEGY 2004-2007 |
- Page 84 and 85: WHO MEDICINES STRATEGY 2004-2007 |
- Page 86 and 87: WHO MEDICINES STRATEGY 2004-2007 |
COMPONENTS OF THE STRATEGY | 27A NATIONAL MEDICINESPOLICY:National <strong>medicines</strong> policies (NMPs) arecommitments to goals and guides for action. Theyprovide frameworks within which priorities areset, the activities of the pharmaceutical sectorcan be coordinated, and legislation developedto support public health needs. They cover boththe public and the private sectors and involveall the main actors in the pharmaceutical field.While recognizing that each country’s situationis unique, WHO proposes 4 that the generalobjectives of <strong>medicines</strong> policies should be toensure:> Access: equitable availability and affordabilityof essential <strong>medicines</strong>> Quality: quality, safety, and efficacy of all<strong>medicines</strong>> Rational use: therapeutically sound andcost-effective use of <strong>medicines</strong> by healthprofessionals and consumers.> presents a formal record ofvalues, aspirations, aims,decisions, and mediumtolong-term governmentcommitments> defines the national goalsand objectives for thepharmaceutical sector, and setspriorities> identifies the strategies neededto meet those objectives, andthe various actors responsiblefor implementing the maincomponents of the policy> creates a forum for nationaldiscussions on these issues.